Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Novartis AG (NVS) vs Royal Caribbean Cruises Ltd (RCL) Price & Performance

Novartis AGTrade
Royal Caribbean Cruises LtdTrade

Price performance (Past 24H)

Key statistics

Novartis AG vs Royal Caribbean Cruises Ltd — how do they compare? Novartis AG trades at $153.53 (market cap $298.18B), while Royal Caribbean Cruises Ltd trades at $307.2 (market cap $82.38B). The key difference: Novartis AG is far larger — about 3.6× Royal Caribbean Cruises Ltd's market cap, and Novartis AG pays the higher dividend (3.02%). Which is the better fit depends on your goals.

NVSRCL
Market Cap
$298.18B$82.38B
Sector
HealthConsumer Cyclical
52-Week High
$168.62$365.84
52-Week Low
$119.31$246.71
Enterprise Value
$339.50B$105.02B
Dividend Yield
3.02%1.62%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Novartis AG

Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.

Read more on NVS

About Royal Caribbean Cruises Ltd

Royal Caribbean is the world's second-largest cruise company, operating 64 ships across five global and partner brands in the cruise vacation industry, with 10 more ships on order. Brands the company operates include Royal Caribbean International, Celebrity Cruises, and Silversea. The company also has a 50% investment in a joint venture that operates TUI Cruises and Hapag-Lloyd Cruises, allowing it to compete on the basis of innovation, quality of ships and service, variety of itineraries, choice of destinations, and price. The company completed the divestiture of its Azamara brand in the first quarter of 2021.

Read more on RCL